Afatinib Reverses EMT via Inhibiting CD44-Stat3 Axis to Promote Radiosensitivity in Nasopharyngeal Carcinoma

Huichao Huang(Central South University), Yongheng Chen(Central South University)
Pharmaceuticals
December 27, 2022
Cited by 84


Related Papers